{"id":529674,"date":"2021-08-19T08:03:48","date_gmt":"2021-08-19T12:03:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/"},"modified":"2021-08-19T08:03:48","modified_gmt":"2021-08-19T12:03:48","slug":"ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/","title":{"rendered":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Aug.  19, 2021  (GLOBE NEWSWIRE) &#8212; Ensysce Biosciences, Inc. (\u201cEnsysce\u201d or the \u201cCompany\u201d) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced it will sponsor a\u00a0satellite symposium at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NeoP4h1C_Z5qJggueHUrnos6IBOmKnU2z2QLH5IzFGkl3BRXHIibnx-0-2R0u5LAw_6CA7K61cmHK9SPrVDmMjcbTdpxc123aZ8-0ZpFjb8PwbyYK4TlK5F-SeGW7_TD\" rel=\"nofollow noopener\" target=\"_blank\">PAINWeek 2021<\/a> on Thursday, September 9 from 3:40 p.m. to 4:30 p.m. Eastern Time (12:40 p.m. to 1:30 p.m.\u00a0Pacific Time) in Castellana 1 Ballroom, The Cosmopolitan of Las Vegas. The theme of the\u00a0symposium is titled \u201cBeyond ADF Opioids: A Next Generation with Abuse and Overdose Protection\u201d and is Chaired by Dr. Jeffrey Gudin.<\/p>\n<p>The PAINWeek Conference is the premier U.S. pain conference with the most expansive curriculum and is the favorite destination for frontline practitioners to enhance their competence in pain management.<\/p>\n<p>\u201cWe are faced with multiple public health crises, including COVID-19 and overdose deaths, yet most often overlooked are the chronic pain patients,\u201d said Dr. Gudin. \u201cI look forward to discussing the important developments in the pain-management space including an opioid with built in abuse and overdose protection with FDA Fast-track status. This type of product would truly represent a breakthrough for pain patients in need.\u201d<\/p>\n<p>Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences, commented: \u201cOur mission is to transform pain treatment and provide a much needed solution to the opioid crisis. We believe our approach can contribute to making opioid pain relief a more acceptable therapeutic option in the future, and we remain focused on our commitment to stem the prescription drug abuse epidemic by bringing our unique pipeline of products to the industry, which will ultimately provide safer options for both prescribers and patients.\u201d<\/p>\n<p>\n        <strong>About Ensysce Biosciences (NASDAQ: ENSC)<\/strong><br \/>\n        <br \/>Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin-Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPAR\u2122) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce\u2019s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tjPVcgShNYiAyykXQVX0TvK_etuSyT-ezfoAPavEcdH6s4ZG0sHhX7ernzMsNNnkWpjoM2NWFGKApv6RrU9Izw==\" rel=\"nofollow noopener\" target=\"_blank\">www.ensysce.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains certain forward-looking statements within the meaning of federal securities laws. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this communication. Such factors can be found in Ensysce\u2019s most recent annual report on Form 10-K, subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K, which are available, free of charge, at the SEC\u2019s website at www.sec.gov, and also in the Form S-4 and Ensysce\u2019s definitive proxy statement\/prospectus filed on June 16, 2021. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect the Company. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Ensysce undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, changes in expectations, future events or otherwise.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Gateway Investor Relations<br \/>Matt Glover, Alex Thompson<br \/>(949) 574-3860<br \/>Ensysce@gatewayir.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Yzc0OWQxZWItOWI5Yy00YTE4LWJlZjAtZTBjZWQ0YTg4YWM5LTEyMjEwMTM=\/tiny\/Ensysce-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Ensysce Biosciences, Inc. (\u201cEnsysce\u201d or the \u201cCompany\u201d) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced it will sponsor a\u00a0satellite symposium at PAINWeek 2021 on Thursday, September 9 from 3:40 p.m. to 4:30 p.m. Eastern Time (12:40 p.m. to 1:30 p.m.\u00a0Pacific Time) in Castellana 1 Ballroom, The Cosmopolitan of Las Vegas. The theme of the\u00a0symposium is titled \u201cBeyond ADF Opioids: A Next Generation with Abuse and Overdose Protection\u201d and is Chaired by Dr. Jeffrey Gudin. The PAINWeek Conference is the premier U.S. pain conference with the most expansive curriculum and is the favorite destination &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-529674","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Ensysce Biosciences, Inc. (\u201cEnsysce\u201d or the \u201cCompany\u201d) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced it will sponsor a\u00a0satellite symposium at PAINWeek 2021 on Thursday, September 9 from 3:40 p.m. to 4:30 p.m. Eastern Time (12:40 p.m. to 1:30 p.m.\u00a0Pacific Time) in Castellana 1 Ballroom, The Cosmopolitan of Las Vegas. The theme of the\u00a0symposium is titled \u201cBeyond ADF Opioids: A Next Generation with Abuse and Overdose Protection\u201d and is Chaired by Dr. Jeffrey Gudin. The PAINWeek Conference is the premier U.S. pain conference with the most expansive curriculum and is the favorite destination &hellip; Continue reading &quot;Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-19T12:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021\",\"datePublished\":\"2021-08-19T12:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/\"},\"wordCount\":603,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/\",\"name\":\"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\",\"datePublished\":\"2021-08-19T12:03:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/","og_locale":"en_US","og_type":"article","og_title":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk","og_description":"SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) &#8212; Ensysce Biosciences, Inc. (\u201cEnsysce\u201d or the \u201cCompany\u201d) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced it will sponsor a\u00a0satellite symposium at PAINWeek 2021 on Thursday, September 9 from 3:40 p.m. to 4:30 p.m. Eastern Time (12:40 p.m. to 1:30 p.m.\u00a0Pacific Time) in Castellana 1 Ballroom, The Cosmopolitan of Las Vegas. The theme of the\u00a0symposium is titled \u201cBeyond ADF Opioids: A Next Generation with Abuse and Overdose Protection\u201d and is Chaired by Dr. Jeffrey Gudin. The PAINWeek Conference is the premier U.S. pain conference with the most expansive curriculum and is the favorite destination &hellip; Continue reading \"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-19T12:03:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021","datePublished":"2021-08-19T12:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/"},"wordCount":603,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/","name":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=","datePublished":"2021-08-19T12:03:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxMTgyOCM0MzY1OTI5IzIyMDk0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ensysce-biosciences-to-host-satellite-symposium-with-dr-jeffrey-gudin-at-painweek-2021-on-september-9-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/529674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=529674"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/529674\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=529674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=529674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=529674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}